Mathias Langhans has worked in various functions at Siemens for over 15 years and has been responsible for Siemens Digital Industries as an Account Developer for Dairy for almost 2 years.
Siemens offers a broad range of technologies which enable dairies to be more effective and competitive in respect to production costs, quality and efficiency. As part of the Siemens Global F&B Community Henrik, Mathias and their colleagues have a lot of experiences on how digitalization can benefit a dairy along the value chain. In his speech he will highlight the latest trends on automation and digitalization and also cover the importance of cyber security in global companies and how to take the necessary measures to prevent production break downs.
Henrik Ruff is working in Siemens Digital Industries in Denmark as the Global Account Manager for Arla Foods. Siemens offers a broad range of technologies which enable dairies to be more effective and competitive in respect to production costs, quality and efficiency. As part of the Siemens Global F&B Community Henrik, Mathias and their colleagues have a lot of experiences on how digitalization can benefit a dairy along the value chain. In his speech he will highlight the latest trends on automation and digitalization and also cover the importance of cyber security in global companies and how to take the necessary measures to prevent production break downs.
Extensive expertise in EMC and Safety Design for Medical Devices, Risk Management and Process Development, Regulatory strategy planning and execution for US, EU and global markets.
Experience in CT, MR, Ultrasound, EP imaging, Interventional Catheters, Mammo, Molecular imaging.
Outstanding success in developing and implementing globally compliant Quality Management Systems for independent and corporate environment activity. Business partner
Hadar owns B.Sc. in Chemical engineering From BGU (Ben-Gurion University of the Negev) & B.Sc. in Polymer engineering from Shankar College of Engineering experienced in leading R&D projects in Biopharmaceutical companies.
Worked in Perrigo API performing commercial procurement for the API division, joined Teva in 2011 as Senior procurement manager in R&D performing global procurement.
Since joining Clinical Supply Chain group, within TEVA’s R&D global clinical operations in 2018, Hadar been leading clinical supply chain projects within verity of programs and TAs, each one includes multiple clinical trials in different clinical phases, identifying unique challenges and tailoring the project planning accordingly with ongoing risk management in accordance with international guidelines and regulations.
She holds various responsibilities including plan efficient drug product demands, coordinating the manufacturing with CMC in all TEVA’s manufacturing plants, sourcing of comparators, plan and design the clinical drug packaging and labeling, Design IRT/RTSM system, set-up and oversee maintenance and overall ensure timely delivery within specifications, quality and standards.
Hadar initiated and led new approach for P&L at Teva, and manage the first large scale ‘Direct to patient’ (DTP) study, implement also new IRT system to support it.
Michal Klein, B Pharm , MHA , Quality Unit Manager and QP at Roche Israel , Experienced Quality Assurance Manager with a demonstrated history of working in the Pharmaceutical industry and as a GMP/GDP inspector of the Israeli Ministry of Health Institute for Standardization and Control of Pharmaceuticals
Aurélie Schwarzbach has over 15 years of experience in the clinical research field. She is currently a senior project manager at Gamida Cell, a Jerusalem-based company, that she joined 7 years ago. She has been managing several clinical activities in studies of different phases, mainly Phase I-II and Phase III studies. More recently, she has orchestrated the clinical activities and documents preparation for the submission of a Biologics License Application (BLA) for omidubicel, an advanced cell therapy of Gamida Cell advanced cell therapies (www.gamida-cell.com).
